Every SEC Form 3/4/5 on record for this filer (CIK 1444612) — 5 issuers, 30 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| HPQ | HP INC | Director | 2023-11-03 → 2026-04-20 | 5 | — |
| EIKN | Eikon Therapeutics, Inc. | Director | 2026-02-04 → 2026-02-04 | 1 | — |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director · lapsed | 2023-10-16 → 2024-06-20 | 4 | $176,000 |
| MRNA | Moderna, Inc. | Chief Financial Officer · lapsed | 2020-06-09 → 2022-08-11 | 8 | −$147,692 |
| AMGN | AMGEN INC | EVP & CFO · lapsed | 2015-08-04 → 2019-11-25 | 19 | −$2M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PACB | 2024-03-06 | Buy | 40,000 | $4.40 | $176,000 | 40,000 |
| MRNA | 2022-08-10 | Sell | 164 | $173.66 | $28,480 | 2,857 |
| MRNA | 2022-05-10 | Sell | 156 | $133.71 | $20,859 | 2,583 |
| MRNA | 2022-02-10 | Sell | 619 | $158.89 | $98,353 | 2,391 |
5 of 5 issuers are covered and open a security page; the rest are on file here only.
